98 related articles for article (PubMed ID: 24836056)
1. Toward a smarter prostate cancer screening program.
Sjoberg DD
Eur Urol; 2015 Oct; 68(4):598-9. PubMed ID: 24836056
[No Abstract] [Full Text] [Related]
2. Re: Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-Specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
Taneja SS
J Urol; 2015 Aug; 194(2):393-4. PubMed ID: 26195364
[No Abstract] [Full Text] [Related]
3. The Era of Prostate-specific Antigen-based Personalized Prostate Cancer Screening Has Only Just Begun.
Schlomm T
Eur Urol; 2015 Aug; 68(2):214-5. PubMed ID: 25680240
[No Abstract] [Full Text] [Related]
4. Prostate cancer: Rescreening policies and risk calculators.
Roobol MJ
Nat Rev Urol; 2014 Aug; 11(8):429-30. PubMed ID: 24980199
[No Abstract] [Full Text] [Related]
5. The dilemmas of prostate cancer screening.
Hugosson J; Carlsson SV
Med J Aust; 2013 Jun; 198(10):528-9. PubMed ID: 23725256
[No Abstract] [Full Text] [Related]
6. Should we screen for prostate cancer? A re-examination of the evidence.
Del Mar CB; Glasziou PP; Hirst GH; Wright RG; Hoffmann TC
Med J Aust; 2013 Jun; 198(10):525-7. PubMed ID: 23725255
[No Abstract] [Full Text] [Related]
7. Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis'.
Carlsson S; Assel M; Vickers A
Ann Oncol; 2015 May; 26(5):1031. PubMed ID: 25646367
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen screening for prostate cancer in males older than 75 years.
Luján M; Páez Á
Med Clin (Barc); 2019 Mar; 152(6):237-240. PubMed ID: 30220470
[No Abstract] [Full Text] [Related]
9. Next-generation prostate-specific antigen test: ready to use?
Bjartell AS
Eur Urol; 2013 Nov; 64(5):700-2. PubMed ID: 23850253
[No Abstract] [Full Text] [Related]
10. Reply to the letter to the editor 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis' by Louie et al.
Louie KS; Seigneurin A; Cathcart P; Sasieni P
Ann Oncol; 2015 May; 26(5):1031-1032. PubMed ID: 25672895
[No Abstract] [Full Text] [Related]
11. Managing localized prostate cancer in the era of prostate-specific antigen screening.
Brooks JD
Cancer; 2013 Nov; 119(22):3906-9. PubMed ID: 24006273
[TBL] [Abstract][Full Text] [Related]
12. Doing it right: how, not whether, to perform prostate-specific antigen screening.
Martin NE
Eur Urol; 2015 Sep; 68(3):361-2. PubMed ID: 25794459
[No Abstract] [Full Text] [Related]
13. Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial.
Shoag J; Halpern J; Eisner B; Lee R; Mittal S; Barbieri CE; Shoag D
JAMA Oncol; 2015 Oct; 1(7):984-6. PubMed ID: 26291583
[No Abstract] [Full Text] [Related]
14. The dilemmas of prostate cancer screening.
Del Mar CB
Med J Aust; 2013 Nov; 199(9):584. PubMed ID: 24182218
[No Abstract] [Full Text] [Related]
15. The dilemmas of prostate cancer screening.
Hugosson J; Carlsson SV
Med J Aust; 2013 Nov; 199(9):583-4. PubMed ID: 24182217
[No Abstract] [Full Text] [Related]
16. The dilemmas of prostate cancer screening.
Lawrentschuk N; Murphy DG; Costello AJ
Med J Aust; 2013 Nov; 199(9):583. PubMed ID: 24182216
[No Abstract] [Full Text] [Related]
17. The dilemmas of prostate cancer screening.
Haines IE
Med J Aust; 2013 Nov; 199(9):582-3. PubMed ID: 24182215
[No Abstract] [Full Text] [Related]
18. The dilemmas of prostate cancer screening.
McKenzie PR; Delahunt B; Kench JG
Med J Aust; 2013 Nov; 199(9):582. PubMed ID: 24182214
[No Abstract] [Full Text] [Related]
19. The dilemmas of prostate cancer screening.
Miklos GG
Med J Aust; 2013 Nov; 199(9):582. PubMed ID: 24182213
[No Abstract] [Full Text] [Related]
20. Prostate cancer screening can save lives but it is too early for a national programme, study finds.
Sayburn A
BMJ; 2014 Aug; 349():g5055. PubMed ID: 25102993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
